Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals

• Main Authors: Ahmad Alamer (Author), Abdulaali R. Almutairi (Author), Shiraz Halloush (Author), Ahmed Al-jedai (Author), Ahmed Alrashed (Author), Mashael AlFaifi (Author), Yahya Mohzari (Author), Malak Almutairi (Author), Fatimah AlHassar (Author), Jude Howaidi (Author), Wedad Almutairi (Author), Ivo Abraham (Author), Nimer Alkhatib (Author)
• Format: Book
• Published: Elsevier, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: We aimed to evaluate the cost effectiveness of Favipiravir treatment versus standard of care (SC) in moderately to severely ill COVID-19 patients from the Saudi healthcare payer perspective. Methods: We used the patient-level simulation method to simulate a cohort of 415 patients with moder...